Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAMP4 Therapeutics
Biotech
Takeda taps longtime Lilly exec as US head—Chutes & Ladders
Takeda taps longtime Lilly exec as US head. Biotech vet enters struggling Arena. Former Pfizer leader joins precocious biotech startup.
Darren Incorvaia
,
Zoey Becker
Sep 12, 2025 8:30am
Upstream swells IPO to $255M as it lists alongside CAMP4
Oct 11, 2024 5:18am
CAMP4 is latest to eye IPO, while Upstream spells out $182M plan
Oct 7, 2024 8:44am
BioMarin goes CAMPing, striking RNA deal with biotech
Oct 1, 2024 9:55am
Equipped with $100M in new cash, CAMP4 takes trail to the clinic
Jul 20, 2022 6:00am
Romanelli returns to Merck after brief CEO role—Chutes & Ladders
Apr 22, 2022 9:30am